RIPK3 and diabetic kidney disease: Previous studies have demonstrated that RIPK3 can regulate signaling pathways independent of necroptosis.[15, 16] In this study, podocyte‐specific RIPK3‐knockout (KO) mice were employed to clarify the role of RIPK3 in DKD, combined with pharmacological targeting of RIPK3 to evaluate its therapeutic effects on DKD.